| Literature DB >> 25889772 |
Ihab S Ramadaan1,2, Karsten Peick3, David A Hamilton4, Jamie Evans5, Douglas Iupati6, Anna Nicholson7, Lynne Greig8, Robert J W Louwe9.
Abstract
BACKGROUND: Re-contouring of structures on consecutive planning computed tomography (CT) images for patients that exhibit anatomical changes is elaborate and may negatively impact the turn-around time if this is required for many patients. This study was therefore initiated to validate the accuracy and usefulness of automatic contour propagation for head and neck cancer patients using SmartAdapt® which is the deformable image registration (DIR) application in Varian's Eclipse™ treatment planning system.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25889772 PMCID: PMC4465143 DOI: 10.1186/s13014-015-0372-1
Source DB: PubMed Journal: Radiat Oncol ISSN: 1748-717X Impact factor: 3.481
Clinical information for the 8 head and neck cancer patients included in this study
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|
|
| L Tonsil | L Tonsil | R Tonsil | Nasopharynx | L Tongue | R Tonsil | Para-nasal sinus | Tongue |
|
| 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 |
|
| Yes | No | No | No | Yes | No | Yes | No |
|
| T2N1M0 | T3N2bM0 | T1N0M0 | T1N0M0 | T2N2bM0 | T2N2M0 | T4N2M0 | T4N3aM0 |
|
| 14.1a | 88.8 | 26.2 | 82.8 | - | 47.5 | - | 201.1 |
|
| 201.8 | 446.1 | 144.6 | 567.5 | 299.4 | 314.1 | - | 179.1b |
|
| - | - | - | - | 214.3 | - | 583.4 | 331.7 |
|
| 68.5 | 186.8 | 38.8 | 153.2 | 57.7 | 108.1 | - | - |
|
| PET | PET | - | MRI | MRI | - | MRI | - |
|
| 2 | 3 | 2 | 2 | 2 | 2 | 3 | 2 |
|
| 42 | 26/42 | 36 | 30 | 25 | 35 | 42/69 | 31 |
|
| 25 | 8/24 | 21 | 16 | 7 | -c | -c/20 | 20 |
|
| −7.1 | −10.7/+0.8 | −1.3 | −3.8 | −2.6 | 0.0 | +1.6/- 0.8 | −6.8 |
|
| Tumour shrinkage | Patient position | Swelling | Patient position | Swelling | Patient position | Patient position | Tissue Loss |
|
| Yes | Yes/No | Yes | No | No | No | No/No | No |
|
| Yes | Yes/Yes | Yes | No | No | No | NA/No | No |
aThis GTV represents a node that was not removed during surgery.
bThe low dose CTV for this patient was adjacent to and did not include the high dose CTV as usual.
cInitial start of RT was delayed due to clinical reasons. Second CT was acquired prior to actual start of RT.
DSI scores reflecting the overlap between the DIR-generated and RO re-contoured structures on a repeat CT-scan
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|
|
| 0.80 | 0.83 | 0.84 | 0.89 | 0.93 | 0.77 |
|
| ||
|
| 0.88 | 0.89 | 0.84 | 0.87 | 0.91 | 0.92 | 0.84 |
|
| |
|
| 0.91 | 0.88 | 0.86 |
|
| |||||
|
| 0.85 | 0.92 | 0.82 | 0.89 | 0.87 | 0.94 |
|
| ||
|
| 0.83 | 0.96 | 0.67 | 0.92 | 0.88 | 0.91 | 0.80 | 0.68 |
|
|
|
| 0.78 | 0.84 | 0.73 | 0.75 | 0.74 | 0.78 | 0.77 | 0.63 |
|
|
|
| 0.73 | 0.76 | 0.79 | 0.74 | 0.90 | 0.90 | 0.77 | 0.54 |
|
|
|
| 0.82 | 0.77 | 0.84 | 0.86 | 0.82 | 0.91 | 0.82 | 0.71 |
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
CTVx denotes the clinical target volume with a dose prescription of x Gy.
DSI scores reflecting the overlap between the DIR-generated and RO-modified structures on a repeat CT-scan
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|
| GTV | 0.90 | 0.83 | 0.99 | 0.97 | 0.98 | 0.97 |
|
| ||
| CTV54 | 0.95 | 0.97 | 0.99 | 0.98 | 0.99 | 0.99 | 0.96 |
|
| |
| CTV60 | 0.99 | 0.94 | 0.97 |
|
| |||||
| CTV66 | 0.97 | 0.87 | 0.95 | 0.98 | 0.98 | 0.98 |
|
| ||
| Brain Stem | 0.86 | 1.00 | 0.68 | 0.98 | 0.98 | 0.95 | 0.87 | 0.65 |
|
|
| Spinal Cord | 1.00 | 0.95 | 0.82 | 0.89 | 0.89 | 0.91 | 0.77 | 0.91 |
|
|
| R Parotid | 0.89 | 1.00 | 1.00 | 0.98 | 0.98 | 0.95 | 0.90 | 0.95 |
|
|
| L Parotid | 0.93 | 1.00 | 0.88 | 0.98 | 0.97 | 0.94 | 0.85 | 0.74 |
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
CTVx denotes the clinical target volume with a dose prescription of x Gy.
Figure 1Histogram of the differences between DSI scores for RO re-contoured and RO-modified structures. The bars include the data of all structures of patients P1-P8 as displayed in Tables 1 and 2.
DSI scores reflecting the overlap between DIR-generated and RO re-contoured structures for CT2 and CT3
|
|
| |||
|---|---|---|---|---|
|
|
|
|
| |
|
| 0.83 | 0.66 | ||
|
| 0.89 | 0.87 | ||
|
| 0.88 | 0.89 | ||
|
| 0.92 | 0.79 | ||
|
| 0.96 | 0.84 | 0.80 | 0.82 |
|
| 0.84 | 0.75 | 0.77 | 0.79 |
|
| 0.76 | 0.82 | 0.77 | 0.74 |
|
| 0.77 | 0.83 | 0.82 | 0.81 |
|
|
|
|
|
|
|
|
|
|
|
|
CTVx denotes the clinical target volume with a dose prescription of x Gy.
Figure 2Relation between quantitative and qualitative analysis results. Solid markers: DSI scores reflecting the overlap between DIR-generated structures and the RO re-contoured structures as a function of the qualitative assessment score upon review by the RO.
Time required by the ROs in minutes to adapt DIR-generated structures or re-contoured structures from scratch
|
|
|
|
|
|
|---|---|---|---|---|
| P1 | CT2 | 30 (±10) | 54(±1) | 24 |
| P2 | CT2 | 30(±10) | 86(±1) | 56 |
| P2 | CT3 | 30(±10) | 90(±1) | 60 |
| P3 | CT2 | 30(±10) | 89(±1) | 59 |
| P4 | CT2 | 30(±10) | 72(±1) | 42 |
| P5 | CT2 | 30(±10) | 50(±1) | 20 |
| P6 | CT2 | 27(±1) | 20(±1) | −7 |
| P7 | CT2 | 21(±1) | 45(±1) | 24 |
| P7 | CT3 | 15(±1) | 44(±1) | 29 |
| P8 | CT2 | 45(±1) | 120(±1) | 75 |
|
|
|
|
| |
|
|
|
|
|
The values between brackets represent the maximum range of the estimated/measured time (see text).
Figure 3Comparison of DIR-generated (purple), RO re- contoured (green), and initially delineated planning CT structures (yellow). Panels (a/b) show an example where the low soft-tissue contrast induced an incorrect shift of DIR-generated structure of the spinal cord; (c) intra-observer variation in the delineation of the brain stem; (d) uncertainty at the cranial and caudal boundary of C4 delineation due to limited slice resolution; (e/f) difference between DIR-generated and the RO-modified CTV after tumour regression.